
Fintech Aspora raises $53 million to expand cross-border banking for global Indians
Bengaluru: Aspora, a London-headquartered fintech startup focused on providing banking services for immigrant communities, has raised $53 million co-led by Sequoia and Greylock, with participation from Quantum Light Ventures.
The company, which was previously known as Vance, is targeting the global Indian diaspora as its first major customer base.
The latest round follows Aspora's $35 million and a $5 million seed extension last year. Over the past six months, the company has raised a total of $93 million across multiple funding rounds. Founded by Parth Garg in 2022, who dropped out of Stanford University to start the venture, Aspora is building cross-border financial products for non-resident Indians (NRIs) and other diaspora segments.
According to the company, it currently serves 250,000 users, with its primary user base in the UAE. Over the past six months, Aspora's transaction volume has grown from $400 million to more than $2 billion, with users saving over $15 million in fees compared to traditional providers.
Aspora offers zero-fee remittance transfers from the UAE and provides exchange rates identical to market benchmarks displayed on Google, while fees may apply in other markets.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video]
getfittoday
Undo
The company currently operates across the UK, EU, and UAE, and plans to launch in the United States in July 2025, followed by expansion into Canada, Australia, and Singapore by the end of the year.
In addition to institutional investors, Aspora is backed by a group of individual investors that includes Balaji Srinivasan (former CTO, Coinbase), Sundeep Jain (former CPO, Uber), Prasanna Sankar (co-founder, Rippling), and Chad West (former global marketing head, Revolut).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
21 minutes ago
- Time of India
India Consulting World Oil Map for Alternative Sources
Indian refiners are considering West African nations and other alternative energy sources to secure additional fuel supplies, should Iran attempt to block the Strait of Hormuz — a critical choke point for global oil and gas transit —as its conflict with Israel intensifies, said oil industry executives. Since the outbreak of the Iran-Israel hostilities on Friday, top oil ministry officials and industry executives are analysing various scenarios and evaluating all possible responses to potential supply disruptions and price spikes. About 40% of India's total crude imports, and 54% of its liquefied natural gas (LNG) supplies, would be at risk if the conflict leads to a closure of the Strait of Hormuz, the narrow sea passage between Iran and Oman that carries nearly 30% of global oil trade and 20% of LNG shipments. Executives at Indian refiners and gas companies, however, believe Iran won't enforce a blockade, citing history. A potential closure would likely send prices soaring, drawing the US into a direct confrontation with Iran, while alienating Gulf nations and other oil import-dependent countries, executives said. Blocking the strait would not only disrupt Gulf oil and gas exports, including Iran itself, but also hinder imports of essential items. This, an executive said, would serve as a strong deterrent to Tehran. Indian refiners are not resorting to 'panic buying' for now, a second executive said. However, the are prepared for any eventuality, the executive said, adding that 'closure of the strait would shrink the global pool of available oil and gas. No matter how carefully you prepare, every economy would feel the impact of a supply crunch and price spike.' 'If India turns to West Africa for additional supplies, other importers are likely to follow,' another executive said, underscoring the complexity of the situation. India imports about 90% of its crude oil needs, with local refiners relying on the Gulf for a major portion of their supplies. Of India's total crude imports, around 35% comes from Russia, a little over 40% from the Gulf, and the rest from Africa, the US and other sources. Africa's share of imports dropped to 5% in May from 12% in April. In 2024, India sourced 54% of its LNG requirements from the Gulf, with Qatar supplying 80% and UAE the remainder. Qatar, among the world's top three LNG exporters, plays a key role in global gas supply, and any disruption to its exports could send spot LNG prices soaring. Even long-term LNG prices could rise, as 60% of India's long-term contracts are linked to crude rates. The global LNG market is not as evolved as the oil market, with very limited sources of alternative supplies. During the 2022 global energy crisis, a former Gazprom unit reneged on its LNG supply contract with India's GAIL, forcing the latter to cut supplies to domestic users. India does not have strategic gas storage, though it does maintain strategic crude reserves. However, New Delhi does not disclose data on national oil and gas inventories. According to the oil ministry, India has total crude and petroleum product storage 'capacity' equivalent to 74 days of national consumption. This includes strategic reserves that can cover 9.5 days of demand. Total capacity includes inventory at refineries, pipelines, ships enroute, product depots, and empty tanks that can hold crude or refined products, executives said.


Time of India
23 minutes ago
- Time of India
Aquarius Daily Horoscope Today, June 17, 2025: Celebrate quietly, even if alone
Today is about self-recognition. You've walked a long road, made hard choices, and learned quietly. Maybe others didn't clap, maybe no one noticed—but the stars see you. Celebrate how far you've come, even if no one else does. Don't wait for outside approval. Your growth is your own. Sit with a smile and thank yourself for surviving days you thought you couldn't. Today brings peaceful pride. Honour it in your own way. No spotlight is needed—only self-respect and quiet joy. Aquarius Love Horoscope Today In love, let appreciation begin with you. If you're in a relationship, notice how you've become more understanding, more balanced. Share that feeling with your partner, not through drama, but with calm presence. If single, don't feel you are lacking something. You've come far emotionally. Appreciate your healing, and don't settle just to feel accepted. The right person will celebrate you for your depth, not just your smile. Today, speak kindly to yourself. That energy will bring love closer. Aquarius Career Horoscope Today Career shows small signs of recognition today, even if not publicly. A senior or client may notice your consistency. Keep your focus. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo You don't need applause to stay committed. Let your own sense of discipline be your motivation. If others are being celebrated, don't feel small. Your time is coming. Quiet workers often create lasting value. Take one more solid step forward. Your reward is in the progress you feel inside, not just in what the world sees. Aquarius Money Horoscope Today Money matters may not bring sudden gains, but your careful past actions are protecting you today. Maybe you chose not to overspend, maybe you saved quietly—today those choices matter. Give yourself credit. It's okay to feel satisfied with simple financial stability. You may also find a small way to treat yourself without guilt. Do it. Celebrate modest victories. No need to explain your spending or saving choices. Inner pride grows when you respect your own efforts. Aquarius Health Horoscope Today Health is steady but may feel slow. That's not a problem. Healing is happening, but quietly. Maybe your skin feels better, digestion is more stable, or sleep is deeper. These are wins. Celebrate them. If there's still something bothering your body, take comfort in the fact that you're listening now. Continue your slow routines—herbal drinks, warm food, light walks. Avoid comparing your energy to others. Your body is on its own timeline. Honour that. Healing doesn't need to be loud. Discover everything about astrology at the Times of India , including daily horoscopes for Aries , Taurus , Gemini , Cancer , Leo , Virgo , Libra , Scorpio , Sagittarius , Capricorn , Aquarius , and Pisces .

Mint
24 minutes ago
- Mint
Biocon launches QIP to raise ₹4,500 crore
Indian biopharmaceutical firm Biocon Ltd is looking to raise $523 million ( ₹4,500 crore) by selling 11.6% stake through a qualified institutional placement (QIP) issue, showed a term sheet. The company has set a floor price of ₹340.20 per equity share, and an indicative floor price of ₹323.20 per equity share, according to the term sheet reviewed by Mint. The funds will be used to purchase outstanding optionally convertible debentures issued by the company's subsidiary Biocon Biologics from Goldman Sachs AIF schemes, and to repay the company's debts. Biocon has a net debt of about $1.2 billion, excluding structured instruments. BofA Securities India Ltd, Kotak Mahindra Capital, and Goldman Sachs (India) Securities Private Ltd are acting as lead managers to advise Biocon on the fundraise. Also read | Biocon to evaluate merger with subsidiary Biologics The company launched the QIP after market hours on Monday. Biocon's shares closed at ₹356.95 on the NSE on Monday, up 0.44%. The company's market cap is at ₹428.13 billion. Biocon did not immediately respond to a query emailed by Mint. On 23 April, the company's board had approved raising ₹4,500 crore by issuing securities via QIPs, rights issue, or other permissible routes, in one or more tranches. The company had sought shareholder approval for the fundraise via a postal ballot dated 2 May 2025. It had earlier said that it plans to complete the first tranche of equity sale by mid-June 2025. 'These funds will be used to meet financial commitments related to Biocon and its subsidiaries," the company's managing director and chief executive officer Siddharth Mittal had told Mint in an earlier interview. Read this | Biocon Biologicals' IPO only after integrating Viatris: CEO Biocon's board has a committee to evaluate strategic restructuring options, including a merger of its biosimilars arm Biocon Biologics Ltd with Biocon Ltd. The company had previously expressed plans to list the subsidiary on the stock exchanges. '…given the market volatility that we are seeing on the IPO front, the board was of the opinion that we should look at other strategic options, which also includes evaluating a merger," Kiran Mazumdar-Shaw, chairperson, Biocon Group, told investors in a post-earnings earnings call last month. The company's consolidated revenue for FY25 was ₹16,470 crore, up 5% from the previous year, while it reported an Ebitda of ₹4,374 crore and a net profit of ₹1,013 crore. And read | Serum arm to double investment in Biocon unit